{"id":4064,"date":"2023-02-20T16:52:16","date_gmt":"2023-02-20T16:52:16","guid":{"rendered":"https:\/\/mirm-pitt.net\/technologies\/?post_type=avada_portfolio&p=4064"},"modified":"2023-02-20T16:52:16","modified_gmt":"2023-02-20T16:52:16","slug":"treatment-of-ocular-conditions-utilizing-a-histone-protein-deacetylase-inhibitor","status":"publish","type":"avada_portfolio","link":"https:\/\/mirm-pitt.net\/technologies\/patents\/treatment-of-ocular-conditions-utilizing-a-histone-protein-deacetylase-inhibitor\/","title":{"rendered":"Treatment of ocular conditions utilizing a histone\/protein deacetylase inhibitor"},"content":{"rendered":"

Treatment of ocular conditions utilizing a histone\/protein deacetylase inhibitor<\/h1>\n
\n
\n
\n

<\/h2>\n<\/section>\n<\/div>\n<\/div>\n
\n
\n
\n

<\/h2>\n<\/section>\n<\/div>\n<\/div>\n<\/div>
<\/div><\/div><\/div>

Inventors:<\/strong> Steven<\/span> R. Little: Michelle L. Ratay<\/span><\/span>\u00a0<\/span>
\n<\/strong><\/p>\n

Patent Number:<\/strong> 11,253,480<\/p>\n

\n
\n
\n

Abstract<\/h3>\n
\n
\n
A method for treating an ocular disorder in a subject comprising administering a therapeutic agent-loaded carrier to an ocular site of the subject in need thereof, wherein the therapeutic agent is a histone deactylase inhibitor.<\/div>\n<\/section>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>
<\/div>
<\/div>
<\/div>